ArticlePharmaceuticals (Basel, Switzerland)2022

Beneficial Effects of Polydeoxyribonucleotide (PDRN) in an In Vitro Model of Fuchs Endothelial Corneal Dystrophy.

Ida Ceravolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.